JD Health and Peak Pharmaceutical Collaborate on Comprehensive Health Management Solutions
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1d ago
0mins
Source: aastocks
Collaboration Announcement: JD Health has partnered with Beijing Peak Biology Pharmaceuticals to develop a comprehensive health management solution that encompasses screening, diagnosis, treatment, medication, follow-up, and protection.
Service Enhancement Goals: The collaboration aims to improve health service delivery by integrating digital technology and industrial resources, creating a closed-loop service that spans preventive intervention to rehabilitation management.
Analyst Views on 06618
Wall Street analysts forecast 06618 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 06618 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 66.800
Low
Averages
High
Current: 66.800
Low
Averages
High
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.








